H.R. 7090 — Introduced in House

I 118th CONGRESS 2d Session H. R. 7090 IN THE HOUSE OF REPRESENTATIVES January 25, 2024Mr. Kelly of Pennsylvania (for himself and Ms. Houlahan) introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend the Internal Revenue Code of 1986 to exclude from gross income certain compensation to clinical trial participants. 1. Exclusion of compensation provided to participants in clinical trials (a) In general Part III of subchapter B of chapter 1 of the Internal Revenue Code of 1986 is amended by inserting after section 139I the following new section: 139J. Clinical trial payments (a) In general Gross income shall not include any amount received by an individual as payment or reimbursement for participation in an approved clinical trial (including amounts paid or reimbursed for meals, lodging, or other travel expenses incurred in connection with such participation). (b) Approved clinical trial The term approved clinical trial has the meaning given such term in section 2709(d)(1) of the Public Health Service Act (42 U.S.C. 300gg–8(d)(1)). . (b) Clerical amendment The table of sections for part III of subchapter B of chapter 1 of such Code is amended by inserting after the item relating to section 139I the following new item: Sec. 139J. Clinical trial payments. . (c) Effective date The amendment made by this section shall apply to amounts paid after December 31, 2023.